Cheapest GLP-1 Program in 2026: An Honest Cost Comparison

GLP-1 medications have become one of the most talked-about advances in weight management in decades. They are also, at retail price, out of reach for most people. Branded semaglutide and tirzepatide can run $900 to $1,400 per month without insurance. That number stops a lot of people before they even start.

But the retail price is not the only number that matters in 2026. The GLP-1 cost landscape is much wider than it used to be, and if you are shopping based solely on branded drug list prices, you are missing most of the picture.

This guide compares every meaningful category of GLP-1 program available today: branded options with and without insurance, compounded alternatives through telehealth, and what each actually costs when you add up the full bill.

*Compounded semaglutide and compounded tirzepatide are not FDA-approved medications. This article is for informational purposes only and does not constitute medical advice. Results vary. Consult a licensed healthcare provider before starting any weight loss medication.*

---

Why GLP-1 Medications Are So Expensive Without Insurance

The high retail price of branded GLP-1 medications is not accidental. Ozempic, Wegovy, Mounjaro, and Zepbound are each protected by patents, and the manufacturers (Novo Nordisk and Eli Lilly) price accordingly. Wegovy's list price in the U.S. currently sits around $1,349 per month. Zepbound lists at roughly $1,059 to $1,400 per month depending on dose.

Insurance coverage for weight management medications has historically been inconsistent. Many commercial plans exclude anti-obesity medications altogether. Medicare traditionally does not cover weight loss drugs under Part D, though policy has continued to evolve. Even when coverage exists, prior authorization requirements and formulary restrictions mean that coverage on paper does not always translate to coverage in practice.

The result: the majority of people who could benefit from GLP-1 therapy are paying out of pocket, and at retail prices, that simply is not sustainable for most household budgets.

---

The Full Landscape: Types of GLP-1 Programs and What They Cost

Not all GLP-1 programs are the same, and the price differences between them are substantial. Here is the full picture.

*Prices based on publicly available information as of April 2026. Prices are subject to change. Verify current pricing directly with each provider. Compounded medications are not FDA-approved.*

The gap between branded and compounded programs is substantial, and it explains why telehealth platforms offering compounded GLP-1 medications have grown significantly. For someone without insurance coverage for weight loss, compounded semaglutide at $159 per month versus Wegovy at $1,349 per month is not a marginal difference. It is the difference between treatment being financially possible or not.

---

Regulatory Context in 2026: What You Need to Know

Before comparing costs, this context matters.

Compounded semaglutide: The FDA's drug shortage designation for semaglutide has been subject to ongoing legal challenges from the compounding industry. The legal basis for compounding semaglutide has been contested and revised. As of 2026, providers offering compounded semaglutide should be able to clearly explain the regulatory framework under which their compounding pharmacy operates. A legitimate provider will have a clear, current answer. An evasive one is a red flag.

Compounded tirzepatide: The FDA removed tirzepatide from its drug shortage list in late 2024. That change shifted the legal landscape for compounding. Some compounding may still be permissible under specific circumstances, but the regulatory picture is genuinely nuanced. If you are considering compounded tirzepatide, work with a provider that actively monitors the regulatory environment and will only prescribe under legally valid circumstances.

---

Telehealth GLP-1 Programs Compared: What Each Platform Actually Charges

The monthly medication cost is only part of the comparison. The total cost of a GLP-1 program includes the medical consultation, ongoing provider access, and shipping. These are often bundled differently across platforms, making the headline price easy to misread.

*Prices current as of April 2026. Verify all pricing directly with each provider before enrolling. This comparison is based on publicly available information and does not constitute an endorsement of competitor platforms.*

How to read the Ro comparison: Ro charges a monthly membership fee separately from the medication cost. The membership alone is approximately $145 per month. Medication is billed on top of that. When you see someone comparing Ro's "medication price" to Prescriva's $159, they are not comparing the same thing.

How to read the Hims/Hers comparison: Hims has promoted oral semaglutide at a very low introductory price. Injectable compounded semaglutide carries a different price structure and typically requires committing to a multi-month plan upfront. The effective monthly cost for injectable semaglutide is higher than the headline number.

---

What "All-In" Actually Means

Many providers advertise a per-month medication price and bill separately for everything else. To understand what you are actually paying, you need to account for every component.

Consultation fee: Some platforms charge a separate visit fee at intake and again at follow-ups. Prescriva's platform includes the provider consultation in the monthly price.

Dose-based pricing: Semaglutide treatment typically starts at 0.25mg and titrates upward over several months. Some providers charge more at higher doses. If the advertised price reflects the starting dose only, your cost will increase as you progress. Ask what you will pay at 0.5mg, 1mg, and beyond.

Introductory versus refill pricing: A first-month promotional rate is a marketing tool. The refill rate is the number you will pay for the next 12 months. Ask explicitly for the ongoing refill price before you commit.

Shipping: Compounded injectables require temperature-controlled shipping. If shipping is not included in the headline price, add $10 to $20 per shipment to your true monthly cost.

Lab work: Some providers require baseline labs before prescribing, which is a clinically reasonable practice. If those labs are not included in the program price, you may be responsible for ordering and paying for them separately, typically $50 to $200 or more.

Membership or subscription fees: Certain platforms bundle GLP-1 medications into a subscription model that includes cancellation or pause fees. Read the terms before you commit.

The most reliable comparison method is calculating your 90-day all-in cost at each provider, including every component, not just the first-month number.

---

Prescriva's Pricing: What You Are Actually Getting at $159/Month

Prescriva's monthly price for compounded semaglutide is $159. That is the all-in number. It covers:

Licensed provider consultation. Before any prescription is written, a licensed healthcare provider reviews your health history, medications, and clinical suitability. This is a substantive medical review, not an automated questionnaire.

Compounded semaglutide medication. Your prescription is filled by a licensed compounding pharmacy and shipped directly to you.

Shipping. No add-on at checkout.

Ongoing provider access. You have access to your care team after your medication arrives, throughout your treatment.

$159 is not a starting price. It does not go up at higher doses or at month two. There are no separate consultation charges. The number on the pricing page is the number you pay.

For compounded tirzepatide, Prescriva's all-in price is $259/month covering the same components.

---

Does Insurance Cover Any of This?

The short answer for compounded medications: almost certainly not.

Because compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products, they fall outside standard insurance formularies. Even branded Wegovy and Zepbound face significant coverage challenges for weight management specifically.

HSA and FSA funds: If a GLP-1 is prescribed by a licensed provider for a qualifying medical purpose, it may be eligible for reimbursement from a Health Savings Account or Flexible Spending Account. Eligibility varies by plan and administrator. Confirm with your plan before assuming coverage applies.

Employer supplemental benefits: Some employers are adding GLP-1 coverage through supplemental health benefits packages, typically for branded medications rather than compounded options. Worth checking with your HR team.

Insurance appeal: If you have commercial insurance and are considering branded semaglutide or tirzepatide, your provider can submit a prior authorization request. Approval rates vary significantly depending on the insurer, your diagnosis, and the indication. An appeal letter from your clinician can sometimes make the difference when an initial request is denied.

For the majority of people pursuing compounded GLP-1 programs, out-of-pocket payment is the reality. That is exactly why the all-in cost comparison matters so much.

---

How to Get the Best Price on a GLP-1 Program

Here is how to approach cost practically, across all the available options.

If you have commercial insurance: Start with a prior authorization request for branded semaglutide or tirzepatide. If denied, ask your provider to submit an appeal. Manufacturer savings cards (Novo Nordisk's NovoCare for Wegovy, Lilly's savings card for Zepbound) can reduce cost significantly for patients who qualify.

If you have Medicare or Medicaid: Manufacturer savings programs are generally not available. Coverage for weight loss medications through Medicare remains limited. Compounded options via telehealth are typically the most accessible route.

If you are paying out of pocket: Compounded GLP-1 programs from telehealth providers like Prescriva are among the lowest-cost options for a medically supervised program. Use the all-in comparison method above to make sure you are comparing apples to apples.

Regardless of insurance status: Avoid any GLP-1 offer that does not include a licensed prescriber's review, cannot identify the compounding pharmacy by name, or prices well below the $150/month threshold without a clear explanation of what is being cut.

---

Signs a "Cheap" GLP-1 Offer Is Not Legitimate

Lower price is not always a warning sign within the legitimate provider range. But certain patterns should prompt closer scrutiny.

No prescription required. Semaglutide and tirzepatide are prescription medications. Any offer that does not include a licensed prescriber's review is either illegal or not providing what it appears to be.

No pharmacy identified. A legitimate telehealth provider can tell you exactly which licensed compounding pharmacy fills your prescription. If that information is hidden or vague, that matters.

Pricing well below $100 per month. The actual cost structure of licensed medical review, compounding, and shipping makes pricing below $100 very difficult to sustain legitimately. Investigate what is being cut.

No mechanism for follow-up or side effect reporting. You should have a real pathway to reach your care team if you experience side effects. A 72-hour email response window with no clinical follow-up is not adequate oversight.

Semaglutide described as a salt or unnamed derivative. The FDA has specifically flagged semaglutide salts as not equivalent to base semaglutide. Ask the provider explicitly: what form of semaglutide does your pharmacy dispense?

Inability to explain current regulatory compliance. Given the evolving regulatory picture for both semaglutide and tirzepatide, a provider that cannot clearly articulate the current legal basis for their compounding is not one you should trust with your health.

---

How to Start with Prescriva

If you are ready to move forward, the process at Prescriva is straightforward.

1. Complete the online health assessment. Answer questions about your health history, current medications, and what you are hoping to achieve. This takes approximately 10 minutes.
2. A licensed provider reviews your information. If compounded semaglutide or tirzepatide is clinically appropriate for you, they write a prescription. If it is not the right fit, they will explain why and discuss alternatives.
3. Your medication ships from a licensed compounding pharmacy. Directly to your door, with shipping included in the price.
4. Ongoing access to your care team. Questions after your medication arrives are handled by your providers.

Starting price: $159/month for compounded semaglutide, all-inclusive.

---

Frequently Asked Questions

What is the cheapest GLP-1 program in 2026? Among licensed telehealth providers, compounded semaglutide programs from platforms like Prescriva are the lowest cost at $159/month all-inclusive. That covers the provider consultation, medication, and shipping. Brand-name GLP-1 medications without insurance cost $800 to $1,400 per month.

Is there a generic GLP-1 medication available in 2026? No. As of 2026, no generic versions of semaglutide or tirzepatide have been approved in the United States. Patents on branded GLP-1 medications are not expected to expire for several years.

Can I use insurance for a GLP-1 program? Branded GLP-1 medications may be covered by commercial insurance with prior authorization, particularly for type 2 diabetes diagnoses. Coverage for obesity treatment specifically is inconsistent and often excluded. Compounded GLP-1 medications are generally not covered because they are not FDA-approved. Check directly with your insurer.

What is the difference between compounded semaglutide and Ozempic or Wegovy? Ozempic and Wegovy are FDA-approved semaglutide products manufactured by Novo Nordisk under validated standards. Compounded semaglutide is a separate, non-FDA-approved product prepared by a licensed compounding pharmacy under a clinician prescription; it has not undergone FDA review for safety, efficacy, or manufacturing quality and is not interchangeable with FDA-approved products.

Why do some platforms charge $299 when others charge $159? Higher prices do not necessarily mean higher quality within the legitimate provider range. Price variation reflects business model differences, overhead structure, how services are bundled, and pricing strategy. Compare the all-in cost at each provider, not just the headline medication number.

How do I know if a GLP-1 program is legitimate? A legitimate program requires a prescription from a licensed provider, identifies the compounding pharmacy by name, has transparent all-in pricing, and offers a real pathway for side effect reporting and follow-up care. The provider should be able to explain the current regulatory basis for their compounding.

Is compounded semaglutide safe? Compounded semaglutide from a licensed pharmacy is not inherently dangerous, but it does not carry the same regulatory assurance as FDA-approved semaglutide products. Working with a reputable telehealth provider that uses licensed, regulated compounding pharmacies meaningfully reduces risk. There is no clinical trial data directly comparing branded to compounded formulations for weight outcomes.

---

Disclaimer

*This content is for informational purposes only and is not medical advice. Consult your healthcare provider before starting any weight loss medication.*

*Compounded semaglutide and compounded tirzepatide are not FDA-approved and are not the same as, equivalent to, or interchangeable with FDA-approved GLP-1 products (Ozempic, Wegovy, Mounjaro, or Zepbound).*

*Results may vary. Individual outcomes depend on treatment adherence, lifestyle factors, and overall health.*

*All medical services, including prescribing, are provided by independently licensed healthcare providers. Blue Oak Services LLC dba Prescriva is a management services organization and does not practice medicine or make clinical decisions.*

*Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. Prescriva is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly.*

*Pricing comparisons are based on publicly available information as of the publication date. Prices are subject to change. Verify all pricing directly with each provider before enrolling.*

*Regulatory information reflects the state of FDA guidance as of the publication date. Compounding regulations are subject to change. Consult with a licensed provider for current information.*

---

Sources

1. Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." *New England Journal of Medicine.* 2021. PMID: [33567185](https://pubmed.ncbi.nlm.nih.gov/33567185/)
2. Jastreboff AM, et al. "Tirzepatide Once Weekly for the Treatment of Obesity." *New England Journal of Medicine.* 2022. PMID: [35658024](https://pubmed.ncbi.nlm.nih.gov/35658024/)
3. Fruh SM. "Obesity: Risk factors, complications, and strategies for sustainable long-term weight management." *Journal of the American Association of Nurse Practitioners.* 2017. PMID: [29024553](https://pubmed.ncbi.nlm.nih.gov/29024553/)
4. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. FDA.gov.

---

*Related articles: [How Much Does Compounded Semaglutide Cost?](/articles/compounded-semaglutide-cost-2026) | [Compounded Tirzepatide Cost in 2026](/articles/compounded-tirzepatide-cost-2026) | [Compounded Semaglutide Without Insurance](/articles/compounded-semaglutide-without-insurance) | [How to Get a GLP-1 Prescription Online](/articles/how-to-get-glp1-prescription-online)*